CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma
Rhabdomyosarcomas (RMS) are rare and often lethal diseases. It is assumed that the tumor microenvironment (TME) of RMS exerts an immunosuppressive function, but there is currently no systematic analysis of the immune cells infiltrating sarcoma tissue. Focusing on two common types of RMS (alveolar [R...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
25 June 2019
|
| In: |
Scientific reports
Year: 2019, Volume: 9 |
| ISSN: | 2045-2322 |
| DOI: | 10.1038/s41598-019-45551-y |
| Online Access: | Verlag, Volltext: https://doi.org/10.1038/s41598-019-45551-y Verlag, Volltext: https://www.nature.com/articles/s41598-019-45551 
|
| Author Notes: | Jakob Nikolas Kather, Christian Hoerner, Cleo-Aron Weis, Thiha Aung, Christian Vokuhl, Christel Weiss, Monika Scheer, Alexander Marx & Katja Simon-Keller |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 167637535X | ||
| 003 | DE-627 | ||
| 005 | 20240411124335.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190910s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41598-019-45551-y |2 doi | |
| 035 | |a (DE-627)167637535X | ||
| 035 | |a (DE-599)KXP167637535X | ||
| 035 | |a (OCoLC)1341242910 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kather, Jakob Nikolas |d 1989- |e VerfasserIn |0 (DE-588)1064064914 |0 (DE-627)812897587 |0 (DE-576)423589091 |4 aut | |
| 245 | 1 | 0 | |a CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma |c Jakob Nikolas Kather, Christian Hoerner, Cleo-Aron Weis, Thiha Aung, Christian Vokuhl, Christel Weiss, Monika Scheer, Alexander Marx & Katja Simon-Keller |
| 246 | 3 | 3 | |a CD163 plus immune cell infiltrates and presence of CD54 plus microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma |
| 264 | 1 | |c 25 June 2019 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 10.09.2019 | ||
| 520 | |a Rhabdomyosarcomas (RMS) are rare and often lethal diseases. It is assumed that the tumor microenvironment (TME) of RMS exerts an immunosuppressive function, but there is currently no systematic analysis of the immune cells infiltrating sarcoma tissue. Focusing on two common types of RMS (alveolar [RMA] and embryonal [RME]), we performed a comprehensive immunohistochemical analysis of tumor-infiltrating immune cells in the TME. We performed a qualitative estimation of infiltrating immune cells in the tumor microenvironment by an experienced pathologist as well as a quantitative digital pathology analysis. We found that (1) manual and automatic quantification of tumor-infiltrating immune cells were consistent; (2) RME tumors showed a higher degree of immune cell infiltration than RMA tumors but (3) the number of tumor infiltrating lymphocytes was low compared to other solid tumor types; (4) microvascular density correlated with immune cell infiltration and (5) CD163 positive macrophages as well as CD54 positive microvessels were more often detected in RME than in RMA and correlated with patient overall and event free survival. Our systematic analysis provides a comprehensive view of the immune landscape of RMS which needs to be taken into account for developing immunotherapies for this rare type of cancer. | ||
| 650 | 4 | |a blockade | |
| 650 | 4 | |a cancer | |
| 650 | 4 | |a classification | |
| 650 | 4 | |a immune-response | |
| 650 | 4 | |a immunotherapy | |
| 650 | 4 | |a ligand 1 expression | |
| 650 | 4 | |a microvessel density | |
| 650 | 4 | |a mutational landscape | |
| 650 | 4 | |a myeloid cells | |
| 650 | 4 | |a soft-tissue sarcoma | |
| 700 | 1 | |a Hörner, Christian |d 1974- |e VerfasserIn |0 (DE-588)128891130 |0 (DE-627)384629237 |0 (DE-576)297385747 |4 aut | |
| 700 | 1 | |a Weis, Cleo-Aron Thias |d 1985- |e VerfasserIn |0 (DE-588)1062803752 |0 (DE-627)806961198 |0 (DE-576)42022730X |4 aut | |
| 700 | 1 | |a Aung, Thiha |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vokuhl, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Weiß, Christel |d 1958- |e VerfasserIn |0 (DE-588)123287707 |0 (DE-627)082463417 |0 (DE-576)168356104 |4 aut | |
| 700 | 1 | |a Scheer, Monika |e VerfasserIn |4 aut | |
| 700 | 1 | |a Marx, Alexander |d 1956- |e VerfasserIn |0 (DE-588)122478258 |0 (DE-627)705923673 |0 (DE-576)214254488 |4 aut | |
| 700 | 1 | |a Simon-Keller, Katja |d 1981- |e VerfasserIn |0 (DE-588)1029383820 |0 (DE-627)733450520 |0 (DE-576)377255890 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Scientific reports |d [London] : Springer Nature, 2011 |g 9(2019) Artikel-Nummer 9211, 12 Seiten |h Online-Ressource |w (DE-627)663366712 |w (DE-600)2615211-3 |w (DE-576)346641179 |x 2045-2322 |7 nnas |a CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma |
| 773 | 1 | 8 | |g volume:9 |g year:2019 |g extent:12 |a CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41598-019-45551-y |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41598-019-45551 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190910 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1029383820 |a Simon-Keller, Katja |m 1029383820:Simon-Keller, Katja |d 60000 |d 63400 |e 60000PS1029383820 |e 63400PS1029383820 |k 0/60000/ |k 1/60000/63400/ |p 9 |y j | ||
| 998 | |g 122478258 |a Marx, Alexander |m 122478258:Marx, Alexander |d 60000 |d 63400 |e 60000PM122478258 |e 63400PM122478258 |k 0/60000/ |k 1/60000/63400/ |p 8 | ||
| 998 | |g 123287707 |a Weiß, Christel |m 123287707:Weiß, Christel |d 60000 |d 60200 |d 60250 |e 60000PW123287707 |e 60200PW123287707 |e 60250PW123287707 |k 0/60000/ |k 1/60000/60200/ |k 2/60000/60200/60250/ |p 6 | ||
| 998 | |g 1062803752 |a Weis, Cleo-Aron Thias |m 1062803752:Weis, Cleo-Aron Thias |d 60000 |d 63400 |e 60000PW1062803752 |e 63400PW1062803752 |k 0/60000/ |k 1/60000/63400/ |p 3 | ||
| 998 | |g 128891130 |a Hörner, Christian |m 128891130:Hörner, Christian |d 60000 |d 63400 |e 60000PH128891130 |e 63400PH128891130 |k 0/60000/ |k 1/60000/63400/ |p 2 | ||
| 998 | |g 1064064914 |a Kather, Jakob Nikolas |m 1064064914:Kather, Jakob Nikolas |p 1 |x j | ||
| 999 | |a KXP-PPN167637535X |e 3514240213 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title_sort":"CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma","title":"CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma"}],"relHost":[{"pubHistory":["1, article number 1 (2011)-"],"id":{"eki":["663366712"],"issn":["2045-2322"],"zdb":["2615211-3"]},"title":[{"title":"Scientific reports","title_sort":"Scientific reports"}],"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"extent":"12","volume":"9","text":"9(2019) Artikel-Nummer 9211, 12 Seiten","year":"2019"},"note":["Gesehen am 12.07.24"],"language":["eng"],"recId":"663366712","origin":[{"dateIssuedDisp":"2011-","publisher":"Springer Nature ; Nature Publishing Group","dateIssuedKey":"2011","publisherPlace":"[London] ; London"}],"disp":"CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcomaScientific reports"}],"physDesc":[{"extent":"12 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.1038/s41598-019-45551-y"],"eki":["167637535X"]},"person":[{"family":"Kather","display":"Kather, Jakob Nikolas","role":"aut","given":"Jakob Nikolas"},{"role":"aut","given":"Christian","family":"Hörner","display":"Hörner, Christian"},{"role":"aut","given":"Cleo-Aron Thias","family":"Weis","display":"Weis, Cleo-Aron Thias"},{"role":"aut","given":"Thiha","family":"Aung","display":"Aung, Thiha"},{"given":"Christian","role":"aut","display":"Vokuhl, Christian","family":"Vokuhl"},{"role":"aut","given":"Christel","family":"Weiß","display":"Weiß, Christel"},{"display":"Scheer, Monika","family":"Scheer","given":"Monika","role":"aut"},{"role":"aut","given":"Alexander","family":"Marx","display":"Marx, Alexander"},{"display":"Simon-Keller, Katja","family":"Simon-Keller","given":"Katja","role":"aut"}],"titleAlt":[{"title":"CD163 plus immune cell infiltrates and presence of CD54 plus microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma"}],"name":{"displayForm":["Jakob Nikolas Kather, Christian Hoerner, Cleo-Aron Weis, Thiha Aung, Christian Vokuhl, Christel Weiss, Monika Scheer, Alexander Marx & Katja Simon-Keller"]},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"25 June 2019"}],"language":["eng"],"recId":"167637535X","note":["Gesehen am 10.09.2019"]} | ||
| SRT | |a KATHERJAKOCD163IMMUN2520 | ||